EGFR and cancer: A cytotoxic compound derived from the EGFR TK inhibitorerlotinib was synthesized to allow further conjugation to the surfaceof LNO HNPs displaying surface-reactive azide functionalities, whilepreserving the growth inhibitory effect of the parent drug moleculeon human prostate DU145 cancer cells.